The methodical approach also offers options for therapeutic intervention in a variety of other diseases, such as cardiomyopathy [29], Pompe disease [30], Stargardt disease [31] or p53 pathway-related diseases [32], just to name a few. Here, TP53 is linked to cardiomyopathy.